Cargando…
The Need for Individualized Risk Assessment in Cardiovascular Disease
Cardiovascular disease remains the leading cause of death in the era of modern medicine despite major advancements in this field. Current available clinical surrogate markers and blood tests do not adequately predict individual risk of cardiovascular disease. A more precise and sophisticated tool th...
Autores principales: | Lim, Hui Yin, Burrell, Louise M., Brook, Rowena, Nandurkar, Harshal H., Donnan, Geoffrey, Ho, Prahlad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323107/ https://www.ncbi.nlm.nih.gov/pubmed/35887637 http://dx.doi.org/10.3390/jpm12071140 |
Ejemplares similares
-
Plasma Angiotensin Converting Enzyme 2 (ACE2) Activity in Healthy Controls and Patients with Cardiovascular Risk Factors and/or Disease
por: Lim, Hui Yin, et al.
Publicado: (2022) -
Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients
por: Wang, Julie, et al.
Publicado: (2022) -
Global coagulation assays in patients with diabetes mellitus
por: Lim, Hui Yin, et al.
Publicado: (2021) -
Overall Hemostatic Potential Assay Detects Risk of Progression to Post-Thrombotic Syndrome in Anticoagulated Patients following Deep Vein Thrombosis
por: McLeod, Blake, et al.
Publicado: (2022) -
Current challenges in the prevention and management of post-thrombotic syndrome—towards improved prevention
por: Wang, Julie, et al.
Publicado: (2023)